The latest fund manager, Proteomics have presented too, and the one which took stock in January. Both those companies have trillions under management, so one would think they are astute with the clients' money and see a good thing with this company's cutting-edge disrupter technology, which will be very much required for health departments all over the world in the future.
Ann: PromarkerD US commercialisation & Promarker pipeline update, page-63
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
85.0¢ |
Change
-0.020(2.30%) |
Mkt cap ! $111.3M | |||
| Open | High | Low | Value | Volume |
| 87.0¢ | 88.0¢ | 84.5¢ | $104.5K | 121.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 12500 | 85.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 87.0¢ | 2526 | 1 |
View Market Depth
| Last trade - 15.32pm 15/08/2024 (20 minute delay) ? |
| PIQ (ASX) Chart |